| Literature DB >> 35593066 |
Ping Wang1, Stephani C Wang2, Xiaoyu Liu3, Shuwei Jia3, Xiaoran Wang3, Tong Li3,4, Jiawei Yu3,5, Vladimir Parpura6, Yu-Feng Wang3.
Abstract
Oxytocin (OT), a nonapeptide, has a variety of functions. Despite extensive studies on OT over past decades, our understanding of its neural functions and their regulation remains incomplete. OT is mainly produced in OT neurons in the supraoptic nucleus (SON), paraventricular nucleus (PVN) and accessory nuclei between the SON and PVN. OT exerts neuromodulatory effects in the brain and spinal cord. While magnocellular OT neurons in the SON and PVN mainly innervate the pituitary and forebrain regions, and parvocellular OT neurons in the PVN innervate brainstem and spinal cord, the two sets of OT neurons have close interactions histologically and functionally. OT expression occurs at early life to promote mental and physical development, while its subsequent decrease in expression in later life stage accompanies aging and diseases. Adaptive changes in this OT system, however, take place under different conditions and upon the maturation of OT release machinery. OT can modulate social recognition and behaviors, learning and memory, emotion, reward, and other higher brain functions. OT also regulates eating and drinking, sleep and wakefulness, nociception and analgesia, sexual behavior, parturition, lactation and other instinctive behaviors. OT regulates the autonomic nervous system, and somatic and specialized senses. Notably, OT can have different modulatory effects on the same function under different conditions. Such divergence may derive from different neural connections, OT receptor gene dimorphism and methylation, and complex interactions with other hormones. In this review, brain functions of OT and their underlying neural mechanisms as well as the perspectives of their clinical usage are presented.Entities:
Keywords: functions; hypothalamus; neurohumoral reflex; oxytocin; supraoptic nucleus
Mesh:
Substances:
Year: 2022 PMID: 35593066 PMCID: PMC9125079 DOI: 10.1177/17590914221100706
Source DB: PubMed Journal: ASN Neuro ISSN: 1759-0914 Impact factor: 5.200
Figure 1.Summary of hormonal functions of oxytocin (OT). Abbreviations: Adrenaline (Adr), Atrial natriuretic peptide (ANP), Corticosteroids (CorT), Free fatty acids (FFA), Gonadotropin-releasing hormone (GnRH), Hypothalamic-pituitary-adrenal (HPA) axis, Hypothalamic pituitary gonad (HPG) axis, Hypothalamic pituitary thyroid (HPT) axis, Interleukin (IL), and Tumor necrosis factor (TNF)-α.
Figure 2.Outline of neural innervations of OT neurons in the central nervous system. A-C. Magnocellular OT neurons (A), parvocellular OT neurons (B) and their interconnections (C). Note that: Oxytocin (OT, green triangles) neurons in the parvocellular division (smaller triangles) of the paraventricular nucleus (pPVN) likely belong to different functional groups; OT neurons in the supraoptic nucleus (SON) and PVN connect mutually through axon/axon collaterals (dashed blue arrows) or dendrites (red dashed arrows); the downward arrows indicate inhibition evoked by OT activation of GABAergic interneurons. Abbreviations of neural structures: The third ventricle (3rdV), Accessory magnocellular nuclei (AMN), Anterior cingulate cortex (ACC), Amygdala (Amy), Arcuate nucleus (Arc), Anteroventral third ventricle region (AV3 V), Barrington's nucleus (BAR), Bed nuclei of the stria terminalis (BNST), Bulbospinal system (BSS), Caudate putamen (CPu), Dorsal vagal complex (DVC), Hippocampus (Hipp), Hypophyseal portal system (HPS), Inferior colliculus (IC), Insular cortex (InsC), Intermediate lobe of the pituitary (IPit), Lateral hypothalamus area (LHA), Lateral septum (LS), Left auditory cortex (LAC), Locus coeruleus (LC), Mammillary body complex (MB), Median eminence (ME), Medial prefrontal cortex (mPFC), Medial preoptic area (MPOA), Nucleus accumbens (NAc), Nucleus tractus solitarius (NTS), Olfactory bulb (OB), Parabrachial nucleus (PBN), Phrenic motor nucleus (PMN), Periaqueductal gray (PAG), Piriform cortex (Pir), Posterior pituitary (PPit), Raphe nucleus (RN), Spinal dorsal horn (SDH), Spinal ejaculation generator (SEG). Substantia nigra compact part (SNc), Superior cervical ganglion (SCG), Sympathetic excitatory neuron (SEN), Ventromedial hypothalamic nucleus (VMH), Ventral tegmental area (VTA). Neural connections of OT neurons refer to (Knobloch & Grinevich, 2014; Liao et al., 2020; Zhang et al., 2021).
OT Higher Brain Functions and the Underlying Mechanisms.
| Category | Physiologic effects | Neural mechanisms | Pharmacological effects | References |
|---|---|---|---|---|
| Social cognition | (1)Promote their sociability, learning and memory, and locomotor activity while decreasing plasma corticosterone and anxiety. | (2)Desensitizing amygdala by increasing 5-HT in RN, NA in LC, GABA in mPFC and DA in VTA, NAc, and ACC. | (3) IAO can facilitate social recognition and inter-personal synchrony, but alleviate negative symptoms in schizophrenia | (1) ( |
| Pro-social behavior | (4)Promote parenting behavior, pair-bonding, social interaction, and affiliative behavior as well as neonate brain development; reducing fear. | (5) Activating GABA inhibition during delivery; promoting neurite outgrowth and synapse formation; holding normal OT/OTR signaling; inhibiting amygdala. | (6) IAO improves social functioning in ASD patients; activating GABAergic signal in BNST; activating PVN-social brain routes; optimizing OT neuronal activity. | (4) ( |
| Learning and memory | (7) Enhance positive social memory and attenuate memory consolidation and retrieval of non-social stimuli. | (8) Increase OT release in the OBs; enhance cortical information transfer; increase signal-to-noise ratio via GABA action; inhibit neuronal death. | (9) IAO can reduce deficits in safety learning, contextual fear and levels of glucocorticoid; reverse amyloid β-induced hippocampal impairment. | (7) ( |
| Anti-depressive & anxiolysis | (10) Increase self-confidence and inter-personal relationship; decrease cognitive anxiety, social stress, depression and suicidality. | (11) Inhibit amygdala and HPA-axis by activation of PVN GABA action; protect the hippocampus; increase 5-HT release in RN and RN-hippocampal activity. | (12) Cure moderate sub-clinical depression; reverse maternal depression; enhance connectivity of amygdala and bilateral insula and middle CG genotype in patients. | (10) ( |
| Reward | (13) Produce enjoying experience and motivation to rewarding stimuli like pair bonding, prize, gambling, delicious meals; sexual contact, and positive social interaction; promote sociability, suppress social stress, depression and anxiety. | (14) Activate 5-HT and Glu transmission from RN to VTA and VTA to reinforce learning by serotonergic neuron co-transmitter glutamate mesocorticolimbic DA pathway from the VTA to the NAc and PVN; inhibit activities of the HPA axis, amygdala and endogenous opioid system | (15) OT-driven social signals compete with drug-elicited reinforcing signals in brain reward circuitry and enable the rewarding effects of prosocial behavior at the expense of drug-related rewards. It involves DA and glutamatergic systems in NAc, GABA and Glu signals in the CeA, and opioid effect in the VTA. | (13) ( |
| Negative impacts | (16) Create intergroup conflict and violence as well as maternal attacks; postpartum maternal depression following social stress. | (17) Prolonged increase in somatodendritic OT secretion causes post-excitation inhibition of OT neurons, which results in -abnormality of brain and peripheral functions; it is often associated with increase VP secretion and HPA-axis activity | (18) More anhedonia in individuals low in extraversion, trust-altruism, and openness to experience, elevated depressive symptoms recall memories, particularly in non-social context; intrapartum OT application increase morbidity of postnatal depressive symptoms in pregnant women | (16) ( |
Abbreviations: 5-HT, serotonin; ACC, anterior cingulate cortex; ASD, autism spectrum disorder; CeA, central nucleus of the amygdala; DA, dopamine; GABA, ɣ-aminobutyric acid; Glu, glutamate; HPA axis, hypothalamic-pituitary-adrenal (HPA) axis; IAO, intranasal application of OT; LC, Locus coeruleus; mPFC, medial prefrontal cortex; NA, norepinephrine; NAc, nucleus accumbens; OBs, olfactory bulb; OT, oxytocin; OTR, OT receptor; PVN, paraventricular nucleus; RN, raphe nuclei; VP, vasopressin; VTA.
Figure 3.Approaches of OT modulation of the higher brain functions. A-B. Magnocellular OT neurons (A) and parvocellular OT neurons (B). The red font indicates a variety of OT effects (please refer to the text for details). Signs and abbreviations are the same as Figure 2.
Figure 4.Approaches mediating OT effects on the instinctive behaviors and somatosensory processes. A-B. Magnocellular OT neurons (A) and parvocellular OT neurons (B). The red font indicates a variety of targets of OT actions (please refer to the text for details). Abbreviations: Adrenocorticotropic hormone (ACTH), Anterior pituitary (APit), Corticotrophin-releasing hormone (CRH), Follicle-stimulating hormone (FSH), Gonadotropin-releasing hormone (GnRH), Luteinizing hormone (LH), Proopiomelanocortin (POMC), Prolactin (PRL), Thoracic sympathetic preganglionic neurons (TSPN), Thyroid-stimulating hormone (TSH) and Vasopressin (VP). Signs and other abbreviations are the same as Figure 2.
OT Effect on Instinctive Behavior and the Underlying Mechanisms.
| Category | Physiologic effects | Neural mechanisms | Pharmacological effects | References |
|---|---|---|---|---|
| Eating and drinking | (1) Decrease food and drinking intake driven by energy; block consumption of toxic food and increase proactive control over feeding with overweight. | (2) Activate VMH and DVC; change activity of the LH and AN; block alcohol-induced DA release within the NAc; activate paraventricular thalamic neurons and suppress HPA axis. | (3) Improve feeding and social skills of infants with Prader-Willi syndrome; improves feeding of patients with anorexia nervosa and inhibit MCH neuronal activity in the LH. | (1) ( |
| Reproduction | (4) Promote sex processes; stimulate HPG axis activity and ovulation; maintain normal menstruation and pregnancy; determine pulsatile OT release during parturition and breastfeeding and maternal behavior. | (5) Activate OT-DAergic neural pathways; increase GnRH release; activate PVN-VTA/SEG pathways; promote maturation of pulsatile OT release machinery involving the SON, PVN and MB as well as OT neurons-maternal behavior-regulating brain regions. | (6) Improve sexuality and its quality; accelerate parturition; facilitate conditional milk letdown; improve erectile dysfunction in aged people with Parkinson's disease; alleviate menstrual migraine and postpartum mood disorders. | (4) ( |
| Anti-aging | (7) Reduction of OT secretion is accompanied with reduced general health levels, immunity, sexuality and cognitive activity. | (8) Reduced number of OT neurons makes all OT-associated brain functions decrease over time. | (9) Increase functional connectivity of neural circuits involved in social perception; improve emotional stability and body functions | (7) ( |
| Nociception and analgesia | (10) OTR SNP increases pain; OT inhibits chronic somatic pains and visceral pain while reducing panic emotions to injury. | (11) Increase neural activity and neural connections between different brain areas; increase GABAergic signals in the brain and NA signals in spinal cord. | (12) Improve chronic pelvic and low back pains; inhibit the DRG, ACC, PAG, amygdala and NAc regions; increase social proximity and support and anxiolysis. | (10) ( |
| Sleep | (13) Improve sleep quality in postpartum women, cancer survivors, patients with ALS and women with a history of sexual assault. | (14) Inhibit HPA axis and melatonin secretion; cause anxiolytic, anti-depression, sedating effects and emotional stability; regulate MB activity. | (15) Increase respiratory rate and reduce obstructive event duration and oxygen desaturation in patients with sleep apnea. | (13) ( |
Abbreviations: ACC, anterior cingulate cortex; ALS, amyotrophic lateral sclerosis;AN, arcuate nucleus; DA, dopamine; DRG, dorsal root ganglion; DVC, dorsal vagal complex; GABA, ɣ-aminobutyric acid; GnRH, gonadotropin-releasing hormone; HPA axis, hypothalamic-pituitary-adrenal axis; HPG, hypothalamic-pituitary-gonadal axis; LH, lateral hypothalamus; MCH, melanin-concentrating hormone; MB, mammillary body complex; NA, norepinephrine; NAc, nucleus accumbens; OT, oxytocin; OTR, OT receptor; PAG, Periaqueductal gray; PVN, paraventricular nucleus; SEG, Spinal ejaculation generator; SNP, single nucleotide polymorphism; SON, supraoptic nucleus; VMH, Ventromedial hypothalamic nucleus; VP, vasopressin; VTA, ventral tegmental area.
OT Effect on Sensorimotor Activity and the Underlying Mechanisms.
| Category | Physiologic effects | Neural mechanisms | Pharmacological effects | References | |
|---|---|---|---|---|---|
| Visceral activity | Maintain homeostasis of the internal environment by selectively activating or inhibiting parasympathetic and sympathetic nervous system. | OT fibers innervate the DVC in the brainstem and the intermediolateral and sacral parasympathetic nuclei and 80% RVLM-projecting PVN cells in rats are OT neurons. OT can increase parasympathetic nervous activity through the PVN-DVC-vagal-organ pathway and increase sympathetic outflows by RVLM way. In addition, there is a population of OT neurons projecting to sympathetic preganglionic neurons in the upper thoracic spinal cord to increase sympathetic outflows directly. | Anxiolysis, reduce heart rate and cardiac contractility, attenuate hyperventilation, suppress food and water intake of the digestive system, slow gastric emptying and regulate hepatic metabolic activity. | ( | |
| Specific sensation | Olfaction | Modulate main OB cellular activity and enhance neural discrimination of odors. | Increase glutamatergic synaptic transmission from mitral/tufted cells to granule cells and control information flows within the local OB neural circuits and from the OBs to the brain. | Improve olfactory deficits in schizophrenia. | ( |
| Hearing | OT may promote the comparison-decision stage and modulate the activity of auditory system at multiple levels. | OT perikarya and fiber terminals exist extensively in the cochlear nucleus and OT enables long-term synaptic plasticity in the auditory cortex. OT facilitation of auditory fear memory extinction through the activation of the hippocampal-mPFC pathway. | Facilitate the auditory fear memory extinction. | ( | |
| Visualization | Modulate visual information processing and visual activity at both brain levels and at the retina. | OT neurons send axon collaterals to retina and OTR are expressed in retina. | Reduce diabetic retinopathy | ( | |
| Gustation | Increase satiety and decrease daily intake of carbohydrate. | OTRs are present in taste buds throughout the oral cavity and neurons in PBN. Activation of OTRs in cells of the lateral PBN along the taste neural pathway suppresses food consumption. | Reduce the intake of sweet foods in diabetes. | ( | |
| Somatic sensorimotor activity | Receive sensory information and regulate some somatic activities. | OT neurons project to portions of the limbic system, mesencephalon, brain stem, substantia nigra compact part, caudate putamen and spinal cord, which are associated with motor. OT presynaptically inhibits the nociceptive input from the peripheral primary afferent fibers by activating GABA interneuron. OT modulates somatosensory activity mainly through neurohumoral reflexes. | .- | ( | |
Abbreviations: RVLM, the rostral ventrolateral medulla; HTC-8, Human taste cell line; PBN, the parabrachial nucleus.